HIV & Liver Disease 2018 - September 13-15, 2018
Liver disease has emerged as a major cause of morbidity and mortality in individuals infected with HIV, including those infected with HBV and HCV. The HIV & Liver Disease 2018 conference is designed to address the increasingly prevalent clinical issues and challenges associated with HIV and liver disease. The conference brings together internationally renowned experts and clinicians from a variety of disciplines, including hepatology and infectious diseases, who will present and discuss the most current and clinically relevant information pertinent to improving patient outcomes.
The format of the conference provides a unique opportunity for both a formal and informal exchange of information. It features General sessions, with presentations by faculty experts Meet-the Professor lunch roundtable discussions Oral presentations Poster presentations.
The conference will be held at Jackson Lake Lodge, Moran, Wyoming, located inside grand Teton National Park. read more »
Funding for this conference was made possible [in part] by the National Institutes of Health under Award Number 2R13AI071925-08. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Supported by education grants from: Abbott Diagnostics, Dova Pharmaceuticals, Gilead Sciences, Inc., Janssen Therapeutics, Division of Janssen Products, LP, Salix, a division of Valeant Pharmaceuticals North American LLC, and ViiV Healthcare